Many therapeutic molecules used in cancer treatments are highly toxic, often harming healthy tissues and causing significant ...

Commonly prescribed heart medications, including statins and diuretics, do not negatively affect the survival of ...

Thanks to modern therapies, a cancer diagnosis is no longer an automatic death sentence. But many patients still suffer from ...

A one‑year course of T‑DM1 offers excellent cancer‑free survival for early HER2‑positive breast cancer, with far less nerve ...

As is often the case with cancer treatments, many patients are able to benefit from therapy for a time. Tumor activity ...

Some six years after the FDA approved Eli Lilly’s Retevmo to treat lung a | Six years after the FDA approved Eli Lilly’s ...

Vir Biotechnology lands a license agreement with Japan’s Astellas Pharma for its lead drug candidate.

A drug for advanced prostate cancer has shown "remarkable" results in an early-stage trial, experts have said.

A drug for advanced prostate cancer has shown “remarkable” results in an early-stage trial, with patients who had previously stopped being receptive to treatment finding their tumours shrinking, ...

New prostate cancer drug showing ‘remarkable’ results during clinical trial - The new drug, known as VIR-5500, uses a ...

Cancer care in 2026 now relies on immunotherapy, targeted therapy, and multimodality treatment, even in early stages, ...